JAVIER
ESCANED BARBOSA
Profesor asociado de Ciencias de la Salud
César
Morís de la Tassa
Publicaciones en las que colabora con César Morís de la Tassa (6)
2020
-
Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)
International Journal of Cardiology, Vol. 299, pp. 49-55
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2015
-
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
EuroIntervention, Vol. 11, Núm. 3, pp. 336-342
2008
-
Long-Term Clinical Benefit of Sirolimus-Eluting Stents in Patients With In-Stent Restenosis. Results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) Study
Journal of the American College of Cardiology, Vol. 52, Núm. 20, pp. 1621-1627
-
Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: Results of a pooled analysis of two randomized studies
Catheterization and Cardiovascular Interventions, Vol. 72, Núm. 4, pp. 459-467
2006
-
A Randomized Comparison of Sirolimus-Eluting Stent With Balloon Angioplasty in Patients With In-Stent Restenosis. Results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) Trial
Journal of the American College of Cardiology, Vol. 47, Núm. 11, pp. 2152-2160